Short Reads

ESMA MAR Q&A

ESMA MAR Q&A

ESMA MAR Q&A

26.07.2017 NL law

On 6 July 2017, the European Securities and Markets Authority (“ESMA”) released the sixth version of its questions and answers (the “Q&A”) on the Market Abuse Regulation (No. 596/2014) (“MAR”).

ESMA’s update to the Q&A addresses Article 3(1)(26)(d) of MAR, which states that a “closely associated person” includes “a legal person, trust or partnership, the managerial responsibilities of which are discharged” by a person discharging managerial responsibilities (“PDMRs”). ESMA clarified that the reference to “the managerial responsibilities of which are discharged” should be read to cover those cases where a PDMR of an issuer (or a closely associated natural person) takes part in or influences the decisions of another legal person, trust or partnership to carry out transactions in financial instruments of the issuer.

ESMA provides an illustrative example on this point: where a person sits on the administrative, management or supervisory body of an issuer and also on the board of another legal entity where he or she exercises executive or non-executive functions, but without taking part or influencing the decisions of that legal entity to carry out transactions in financial instruments of the issuer, such person should not be considered to be discharging managerial responsibilities within that legal entity for purposes of Article 3(1)(26)(d) of MAR. Accordingly, that legal entity should not be subject to the notification obligations under Article 19(1) of MAR unless it is directly or indirectly controlled by, is set up for the benefit of, or its economic interests are substantially equivalent to those of that person

Team

Related news

27.03.2020 NL law
Actuele ontwikkelingen rondom de AVA’s van beursvennootschappen en corona

Short Reads - Op 23 maart 2020 heeft het Nederlandse kabinet aanvullende overheidsmaatregelen genomen in het kader van de bestrijding van het coronavirus. Deze maatregelen zijn onder meer gericht op evenementen en samenkomsten. In een nieuwsbericht van het kabinet van 24 maart 2020 zijn deze maatregelen nader geduid (zie ook de Q&A die eveneens door het kabinet is gepubliceerd).

Read more

16.03.2020 EU law
Update with respect to COVID-19 – Notification Threshold Net Short Position Holders

Short Reads - On 16 March 2020, the European Securities and Markets Authority (“ESMA”) issued a decision which temporarily requires holders of net short positions in shares traded on European Union regulated markets to notify the relevant national competent authority (“NCA”) if the position reaches or exceeds 0.1% of the issued share capital (see link here).

Read more

25.03.2020 NL law
Key considerations for management and owners of Dutch privately held companies in distress due to COVID-19

Short Reads - The COVID-19 pandemic has a significant and immediate adverse effect on many companies in different industries. Many PE portfolio companies are particularly vulnerable given the typical high leverage finance structure and inherent need to maintain cash flow. To meet these challenges and mitigate liability risks, management and owners may need to take clear and immediate action (and refrain from certain other actions) in the interest of all stakeholders. The following sets out some key legal guidelines for management and owners when dealing with a Dutch subsidiary in distress.

Read more

16.03.2020 NL law
Nieuwe overheidsmaatregelen in verband met coronavirus en actuele ontwikkelingen rondom de AVA’s van beursvennootschappen

Short Reads - Het Nederlandse kabinet heeft in het kader van de bestrijding van het coronavirus nieuwe overheidsmaatregelen afgekondigd. Afgelopen donderdag werd al bekend dat tot en met 31 maart 2020 bijeenkomsten met meer dan 100 personen in heel Nederland niet langer mogelijk zijn.

Read more

12.03.2020 EU law
Stibbe sets up corona team

Inside Stibbe - The coronavirus (COVID-19) may have legal consequences for your business. We have set up a team of specialists who can provide insight into the legal implications of the virus.

Read more

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring